Accessibility Menu
Intelligent Bio Solutions logo

Intelligent Bio Solutions(NASDAQ) GBS

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-100%
5 Year-100%
1 Year-89%
1 Month-19%
N/A
Intelligent Bio Solutions last closing stock price
MetricPriceDate
Last closeUSD 1.812026-07-31
Intelligent Bio Solutions stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.43%USD 1.752026-07-24
1 month-18.83%USD 2.232026-07-01
3 month-24.9%USD 2.412026-05-01
Year to date-81.01%USD 9.532025-12-31
1 year-88.54%USD 15.802025-07-31
3 year-99.18%USD 221.062023-08-01
5 year-99.98%USD 7,776.002021-07-30
Since inception-99.99%USD 26,448.012020-12-23

Intelligent Bio Solutions Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.91M

Net Income (TTM)

-$11.61M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 31, 2022

GBS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intelligent Bio Solutions

Intelligent Bio Solutions makes quick, non-invasive tests for drug screening and health monitoring. Its products help employers, healthcare providers, and legal systems check for drug use or monitor health without needles. The company’s tools give fast results, making testing easier for both users and organizations.

Gadgets That Sniff Out the Truth: Products and Services

  • Fingerprint Drug Screening (100% of revenue): Portable system detects drugs from sweat on a fingertip; used by employers, healthcare, and legal sectors.
  • Drug Screening Cartridges: Single-use cartridges for the fingerprint system; main recurring revenue source.
  • Handheld Readers: Portable devices that analyze cartridges and display results in under 10 minutes.
  • Confirmatory Kits: Lab kits for further testing when initial results need confirmation.
  • Biosensor Platform (0% of revenue): In development; aims to measure health markers like glucose from saliva, not yet commercialized.

From Lab Coats to Construction Sites: Growth and Expansion

  • Acquired fingerprint drug screening business in 2022, expanding into workplace and judicial testing.
  • Partnered with Detecto/MTB Distribuciones Tecnologicas SL in 2024 to enter Spain and Andorra.
  • Added Arabic language support in 2024, targeting Middle East markets.
  • Formed alliance with IVY Diagnostics Srl in 2024 to boost European and Middle Eastern reach.
  • Launched clinical study with CenExel in 2025 for US regulatory approval.

Why This Company Isn’t Just Another Test Kit

Intelligent Bio Solutions operates in 24 countries with over 450 active customer accounts. Its fingerprint drug test is portable, quick, and does not require blood or urine. The company’s recurring cartridge sales model supports stable revenue from existing clients.

Five Things You Need to Know

  • Revenue was $1 million in QQ1 2026, up 27.5% from QQ1 2025.
  • Gross profit was $518,291 in QQ1 2026, up 49.4% year-over-year.
  • Net loss was $-3 million in QQ1 2026, improved by 10.1% from QQ1 2025.
  • Cash and cash equivalents were $4 million in QQ1 2026, up 124.3% year-over-year.

Bottom Line

Intelligent Bio Solutions has shifted from research to commercial sales, focusing on non-invasive drug testing. The company’s recurring revenue model and global reach support its position in workplace and healthcare diagnostics.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

55

CEO

Harry Simeonidis

Website

ibs.inc

Headquarters

New York City, NY 10019, US

GBS Financials

Key Financial Metrics (TTM)

Gross Margin

32.08%

Operating Margin

-300.26%

Net Income Margin

-296.76%

Return on Equity

-174.16%

Return on Capital

-324.73%

Return on Assets

-78.13%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.85M

Operating Income

-$11.68M

EBITDA

-$4.76M

Operating Cash Flow

-$10.95M

Capital Expenditure

-$357.57K

Free Cash Flow

-$11.31M

Cash & ST Invst.

$6.86M

Total Debt

$1.85M

Intelligent Bio Solutions Performance Analysis

Intelligent Bio Solutions annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 0N/A
20232023-06-30USD 1,256,872N/A
20242024-06-30USD 3,111,781147.6%
20252025-06-30USD 3,052,532-1.9%
Intelligent Bio Solutions sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3015.8%
Q12025-09-3031.7%
Q22025-12-31-19.3%
Q32026-03-3118.3%
Intelligent Bio Solutions annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD -1,359.31N/A
20232023-06-30USD -1,269.97-6.6%
20242024-06-30USD -63.77-95.0%
20252025-06-30USD -20.04-68.6%
Intelligent Bio Solutions sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3018.2%
Q12025-09-302.8%
Q22025-12-31-705.7%
Q32026-03-3136.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$1.06M

+45.5%

Gross Profit

$535.38K

+56.8%

Gross Margin

50.47%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

12

N/A

Net Income

-$2.86M

-12.5%

EBITDA

$290.39K

+112.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$6.86M

+144.5%

Total Debt

$1.85M

+261.6%

Accounts Receivable

$878.36K

+71.9%

Inventory

$597.47K

-12.6%

Long Term Debt

$1.46M

+39308.2%

Short Term Debt

$388.75K

-23.4%

Return on Assets

-78.13%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

-$4.32M

-56.7%

Operating Cash Flow

-$4.33M

-57.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PHIOPhio Pharmaceuticals Corp.
$1.03-0.49%
LFLYLeafly Holdings, Inc.
$37.00+0.00%
TFFPTFF Pharmaceuticals, Inc.
$0.07-60.05%
PAVMPAVmed Inc.
$4.95-2.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About GBS

What is the current price of Intelligent Bio Solutions?

Intelligent Bio Solutions is trading at N/A per share.

What is the 52-week range for Intelligent Bio Solutions?

Over the past 52 weeks, Intelligent Bio Solutions has traded between N/A and N/A.

How much debt does Intelligent Bio Solutions have?

As of the most recent reporting period, Intelligent Bio Solutions reported total debt of $1.85M.

How much cash does Intelligent Bio Solutions have on hand?

Intelligent Bio Solutions reported $6.86M in cash and cash equivalents in its most recent financial results.

What is Intelligent Bio Solutions’s dividend yield?

Intelligent Bio Solutions does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services